Trials / Completed
CompletedNCT05638815
An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)
An Observational Study to Explore the Role of Alpha-Synuclein-related Biomarkers in the Diagnosis and Disease Evaluation of Parkinson's Disease and Other Synucleinopathies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 89 (actual)
- Sponsor
- SciNeuro · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The study is a multi-center, observational study to evaluate the feasibility of α-synuclein-related biomarkers and imaging data in the disease diagnosis and prognosis evaluation in Synucleinopathies and healthy subjects.
Detailed description
In the study, a total number of no more than 100 subjects are planned to be enrolled. Subjects who are eligible for enrollment will be enrolled in the study after signing the informed consent form (ICF) and undergo 3 visits, including the baseline visit (the day of first blood sample collection), visit 1 (day 183 post-enrollment), and visit 2 (day 366 post-enrollment).
Conditions
Timeline
- Start date
- 2021-11-23
- Primary completion
- 2023-07-10
- Completion
- 2023-07-10
- First posted
- 2022-12-06
- Last updated
- 2023-11-22
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05638815. Inclusion in this directory is not an endorsement.